Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424964
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-14
Brief Title:
Use of Long-Acting Injectable CabotegravirRilpivirine for the Treatment of HIV in Belgium
Sponsor:
Belgian Research on AIDS and HIV Consortium
Organization:
Belgian Research on AIDS and HIV Consortium
Study Overview
Official Title:
Use of Long-Acting Injectable CabotegravirRilpivirine for the Treatment of HIV in Belgium
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a multi-center single arm observational cohort study with an assessment of patient-reported outcomes PROs and of clinical and virologic outcomes
Primary outcome Evaluate patient perception of and satisfaction with long-acting injectable LAI cabotegravirrilpivirine CABRPV for the treatment of HIV
Secondary outcomes
Description of the demographic HIV- and non-HIV-related characteristics of participants included in this analysis
Primary outcome Evaluate patient perception of and satisfaction with long-acting injectable LAI cabotegravirrilpivirine CABRPV for the treatment of HIV
Secondary outcomes
Description of the demographic HIV- and non-HIV-related characteristics of participants included in this analysis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None